Capecitabine, DNA/RNA Synthesis Inhibitor
Por um escritor misterioso
Descrição
Capecitabine is an oral proagent that is converted to its active metabolite, 5-FU, by thymidine phosphorylase. - Mechanism of Action & Protocol.
5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition - ScienceDirect
Capecitabine, DNA, RNA and Protein Synthesis Inhibitors
Mechanism of action of 5-fluorouracil: Capecitabine is a prodrug that
Capecitabine, C15H22FN3O6
Gupta Cancer Part 2 Flashcards
TAS1553, a small molecule subunit interaction inhibitor of ribonucleotide reductase, exhibits antitumor activity by causing DNA replication stress
Fluoropyrimidine-induced toxicity and DPD deficiency.. A case report of early onset, lethal capecitabine-induced toxicity and mini review of the literature. Uridine triacetate: Efficacy and safety as an antidote. Is it accessible outside
Interference with Nucleic Acid Synthesis - Creative Biolabs
APExBIO - Capecitabine
Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients
Mechanism of Action (MOA) Vistogard®(uridine triacetate) oral granules
DNA Synthesis Inhibitors- Definition, Examples, Inhibition, Resistance
Mapping combinatorial drug effects to DNA damage response kinase inhibitors
Systematic review of treatment intensification using novel agents for chemoradiotherapy in rectal cancer - Clifford - 2018 - BJS (British Journal of Surgery) - Wiley Online Library
Capecitabine API Manufacturer and Supplier
de
por adulto (o preço varia de acordo com o tamanho do grupo)
